search
Back to results

Parathyroid Autofluorescence Visualization in Thyroid Surgery: Impact on Postoperative Hypocalcemia

Primary Purpose

Hypocalcemia

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Near Infrared Camera (NIR)
Sponsored by
Hôpital Européen Marseille
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypocalcemia focused on measuring postoperative hypocalcemia, near infrared imaging, parathyroid autofluorescence

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All patients eligible for one-stage total thyroidectomy, associated or not to lymph node dissection (TT +/- LND).

Exclusion Criteria:

  • Combined parathyroid and thyroid disease (including patients with enlarged parathyroids incidentally found during surgery and resected)

Sites / Locations

  • Hopital Europeen
  • Hôpital Saint Joseph Marseille
  • Hopital La Pitie Salpetriere

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

NIR+ group

NIR- group

Arm Description

Patients who undergo conventional total thyroidectomy (TT)+/- lymph node dissection (LND). Parathyroid identification was done with the use of NIR (intervention group, NIR+ group)

Patients who undergo conventional total thyroidectomy (TT)+/- lymph node dissection (LND) without the use of NIR - parathyroid identification was done by naked eye only (no intervention group, NIR- group)

Outcomes

Primary Outcome Measures

Postoperative hypocalcemia
Postoperative day 1 and day 2 corrected calcemia (hypocalcemia when calcemia <2mmol/l). If hypocalcemia, calcium is measured at 1 month and 6 months

Secondary Outcome Measures

Number of identified parathyroids
identified by naked eye
Number of autotransplanted parathyroids
when parathyroids cannot be left in situ, they are fragmented and reinserted in a sterno-cleido-mastoid muscle
Number of inadvertently resected parathyroids
when parathyroid tissue is found on thyroid specimen (reported on pathology report)

Full Information

First Posted
September 1, 2016
Last Updated
January 4, 2019
Sponsor
Hôpital Européen Marseille
search

1. Study Identification

Unique Protocol Identification Number
NCT02892253
Brief Title
Parathyroid Autofluorescence Visualization in Thyroid Surgery: Impact on Postoperative Hypocalcemia
Official Title
Parathyroid Autofluorescence Visualization in Thyroid Surgery: Impact on Postoperative Hypocalcemia. A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
September 2016 (Actual)
Primary Completion Date
June 2018 (Actual)
Study Completion Date
December 20, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hôpital Européen Marseille

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This Multicenter, Randomized Controlled Trial evaluates the clinical impact of parathyroid autofluorescence visualization using near infrared light (NIR) during total thyroidectomy (TT). It compares patients who undergo TT associated or not with lymph node dissection (LND) with NIR vs without NIR use during surgery.
Detailed Description
Total thyroidectomy (TT) is responsible for postoperative hypocalcemia in 20-30% of patients, which is definitive in 1-4% of operated patients (1). This complication is mainly due to surgery-induced parathyroid dysfunction, which could be improved by a better intraoperative identification of the parathyroids. Intraoperative parathyroid auto-fluorescence visualization (without any dye injection) using near infrared light (NIR) is an emerging technique, which allows correct identification of normal parathyroids in almost all cases (2), but the clinical impact of NIR is unknown. The aim of this prospective, comparative randomized study, is to compare 2 groups of patients: patients operated with NIR (NIR+) vs patients operated without NIR (NIR-). The main objective of this study is to assess the impact of intraoperative use of NIR camera on postoperative hypocalcemia. Secondary objectives are to assess the impact of NIR on the visualization, autotransplantation and inadvertent resection rates during TT.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypocalcemia
Keywords
postoperative hypocalcemia, near infrared imaging, parathyroid autofluorescence

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
241 (Actual)

8. Arms, Groups, and Interventions

Arm Title
NIR+ group
Arm Type
Experimental
Arm Description
Patients who undergo conventional total thyroidectomy (TT)+/- lymph node dissection (LND). Parathyroid identification was done with the use of NIR (intervention group, NIR+ group)
Arm Title
NIR- group
Arm Type
No Intervention
Arm Description
Patients who undergo conventional total thyroidectomy (TT)+/- lymph node dissection (LND) without the use of NIR - parathyroid identification was done by naked eye only (no intervention group, NIR- group)
Intervention Type
Device
Intervention Name(s)
Near Infrared Camera (NIR)
Other Intervention Name(s)
Fluobeam® system (Fluoptics®, Grenoble, France)
Intervention Description
Surgical field is examined with NIR, during a few minutes (<5') with room lights switched off, to avoid parasite lights, then open thyroidectomy is resumed conventionally. Real-time images, evocative of autofluorescent parathyroids, are checked visually. NIR consists of a 750 nm class 1 laser excitation, with a power <20mW/cm2 (5 times less than the limit of 100mw/cm2, fixed by the international standard IEC 60601-2-41). It is provided by the Fluobeam® camera, which is inserted into a sterile cover and hold at a 15-20 cm distance from the patient. The system has an FDA 510(k) authorization for clinical use in parathyroid surgery and a European Community certification (Class 2A device).
Primary Outcome Measure Information:
Title
Postoperative hypocalcemia
Description
Postoperative day 1 and day 2 corrected calcemia (hypocalcemia when calcemia <2mmol/l). If hypocalcemia, calcium is measured at 1 month and 6 months
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Number of identified parathyroids
Description
identified by naked eye
Time Frame
immediate (intraoperative)
Title
Number of autotransplanted parathyroids
Description
when parathyroids cannot be left in situ, they are fragmented and reinserted in a sterno-cleido-mastoid muscle
Time Frame
immediate (intraoperative)
Title
Number of inadvertently resected parathyroids
Description
when parathyroid tissue is found on thyroid specimen (reported on pathology report)
Time Frame
delayed (10 days)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All patients eligible for one-stage total thyroidectomy, associated or not to lymph node dissection (TT +/- LND). Exclusion Criteria: Combined parathyroid and thyroid disease (including patients with enlarged parathyroids incidentally found during surgery and resected)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
BENMILOUD Fares, MD
Organizational Affiliation
Hopital Europeen de Marseille
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
BIDAUT Wahiba, Senior CRA
Organizational Affiliation
Hopital Europeen de Marseille
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
REBAUDET Stanislas, MD
Organizational Affiliation
Hopital Europeen de Marseille
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
PENARANDA Guillaume
Organizational Affiliation
Laboratoire Alphabio
Official's Role
Study Chair
Facility Information:
Facility Name
Hopital Europeen
City
Marseille
ZIP/Postal Code
13003
Country
France
Facility Name
Hôpital Saint Joseph Marseille
City
Marseille
ZIP/Postal Code
13008
Country
France
Facility Name
Hopital La Pitie Salpetriere
City
Paris
ZIP/Postal Code
75013
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
22236412
Citation
Duclos A, Peix JL, Colin C, Kraimps JL, Menegaux F, Pattou F, Sebag F, Touzet S, Bourdy S, Voirin N, Lifante JC; CATHY Study Group. Influence of experience on performance of individual surgeons in thyroid surgery: prospective cross sectional multicentre study. BMJ. 2012 Jan 10;344:d8041. doi: 10.1136/bmj.d8041.
Results Reference
background
PubMed Identifier
26454675
Citation
McWade MA, Sanders ME, Broome JT, Solorzano CC, Mahadevan-Jansen A. Establishing the clinical utility of autofluorescence spectroscopy for parathyroid detection. Surgery. 2016 Jan;159(1):193-202. doi: 10.1016/j.surg.2015.06.047. Epub 2015 Oct 9.
Results Reference
background
PubMed Identifier
31693081
Citation
Benmiloud F, Godiris-Petit G, Gras R, Gillot JC, Turrin N, Penaranda G, Noullet S, Chereau N, Gaudart J, Chiche L, Rebaudet S. Association of Autofluorescence-Based Detection of the Parathyroid Glands During Total Thyroidectomy With Postoperative Hypocalcemia Risk: Results of the PARAFLUO Multicenter Randomized Clinical Trial. JAMA Surg. 2020 Feb 1;155(2):106-112. doi: 10.1001/jamasurg.2019.4613.
Results Reference
derived

Learn more about this trial

Parathyroid Autofluorescence Visualization in Thyroid Surgery: Impact on Postoperative Hypocalcemia

We'll reach out to this number within 24 hrs